News
Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell (iPSC)
Pluristyx and Qkine Announce a Reciprocal Distribution Agreement in Support of Optimized Growth Factor Differentiation of Induced Pluripotent Stem Cell ...
Pep Talk April 2026
Its been an exciting and busy start to the year! Read our newsletter for updates on new distributors, application notes, ...
#FridayRead 24 April 2026
This week’s #Fridayread from the lab of Dr. Natalia Rodriguez-Muela describes the generation of an isogenic panel of hiPSC-derived cortical ...
#FridayRead 10 April 2026
This weeks #Fridayread describes a feeder cell-free culture system based on serum coating that supports long-term maintenance of naive human ...
Pep Talk March 2026
Spring is in the air and we have more data and exciting news to share! Read our newsletter for updates ...
Qkine marks International Women’s Day 2026
Qkine are committed to supporting women across diverse career paths, hear from some of the amazing women that make our ...
Pep Talk February 2026
We've had a busy start to 2026 and share more exciting news for our cell therapy grade and new application ...
BioLife solutions signs multi-year supply agreement with Qkine Limited to expand its product portfolio into the rapidly growing cytokines market
BioLife will distribute certain cytokine and growth factor products manufactured by Qkine for use in cell and gene therapy manufacturing ...
